E
Stakeholder Speakers




BRUCE GELLIN (Sponsor), Deputy Assistant Secretary of Health; Director, National Vaccine Program Office, Department of Health and Human Services

PHYLLIS ARTHUR, Senior Director, Vaccines, Immunotherapeutics and Diagnostics Policy, Biotechnology Industry Organization

JOHN BOSLEGO, Director, Vaccine Development Program, PATH

CARTER DIGGS, Senior Technical Advisor, Malaria Vaccine Development Program, U.S. Agency for International Development

PHILIP ECKHOFF, Research Scientist and Principal Investigator, Disease Modeling Team, Intellectual Ventures

IRENE ECKSTRAND, Scientific Officer, Models of Infectious Disease Agent Study, National Institute of General Medical Sciences, National Institutes of Health

RAINER ENGELHARDT, Assistant Deputy Minister, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada

ALEXANDER GARZA, Assistant Secretary for Health Affairs and Chief Medical Officer, Department of Homeland Security

ANN GINSBERG, Vice President, Scientific Affairs, Aeras

MARION GRUBER, Director, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration

DAVID HAMMER, Product Manager, Joint Vaccine Acquisition Program, Chemical Biological Medical Systems, Department of Defense

CAROLE HEILMAN, Director, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 125
E Stakeholder Speakers BRUCE GELLIN (Sponsor), Deputy Assistant Secretary of Health; Director, National Vaccine Program Office, Department of Health and Human Services ­PHYLLIS ARTHUR, Senior Director, Vaccines, Immunotherapeutics and Diagnostics Policy, Biotechnology Industry Organization ­JOHN BOSLEGO, Director, Vaccine Development Program, PATH ­CARTER DIGGS, Senior Technical Advisor, Malaria Vaccine Development Program, U.S. Agency for International Development ­PHILIP ECKHOFF, Research Scientist and Principal Investigator, Disease Modeling Team, Intellectual Ventures ­ IRENE ECKSTRAND, Scientific Officer, Models of Infectious Disease Agent Study, National Institute of General Medical Sciences, National Institutes of Health ­RAINER ENGELHARDT, Assistant Deputy Minister, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada ­ALEXANDER GARZA, Assistant Secretary for Health Affairs and Chief Medical Officer, Department of Homeland Security ­ANN GINSBERG, Vice President, Scientific Affairs, Aeras ­MARION GRUBER, Director, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration ­DAVID HAMMER, Product Manager, Joint Vaccine Acquisition Program, Chemical Biological Medical Systems, Department of Defense ­CAROLE HEILMAN, Director, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health 125

OCR for page 125
126 RANKING VACCINES: A Prioritization Software Tool ­­SETH HETHERINGTON, Chief Medical Officer, Genocea Biosciences; Member, National Vaccine Advisory Committee ­JOACHIM HOMBACH, Senior Adviser, Department of Immunisation, Vaccines and Biologicals, World Health Organization ­PETER HOTEZ, President, Albert Sabin Vaccine Institute, and Dean, National School of Tropical Medicine, Baylor College of Medicine ROBERT KOLODNER, Chief Health Informatics Officer and Acting Executive Officer, Open Health Tools ­PRASAD KULKARNI, Medical Director, The Serum Institute of India Limited ­DIANA LANCHONEY, Executive Director, Vaccine Ventures and New Products, Merck & Company ­TIMOTHY LANT, Director, Analytic Decision Support, Biomedical Advanced Research and Development Authority, Department of Health and Human Services ­OSMAN MANSOOR, Senior Health Advisor, New Vaccines, United Nations Children’s Fund ­RICHARD MARTINELLO, Chief Consultant, Clinical Public Health, Department of Veterans Affairs ­GENEVIEVE MEIER, Health Economics Manager, North America Vaccines Division, GlaxoSmithKline Vaccines CHRISTOPHER MURRAY, Director, Institute for Health Metrics and Evaluation, University of Washington School of Medicine ­ALEX PALACIOS, Special Representative, GAVI Alliance ­PATRICIA QUINLISK, Medical Director, Iowa Department of Health ­ROBIN ROBINSON, Director, Biomedical Advanced Research and Development Authority, Department of Health and Human Services ­JEFFREY STURCHIO, Senior Partner, Rabin Martin MELINDA WHARTON, Deputy Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention